News
Breakthrough infections twice as likely to be asymptomatic
September 1, 2021
New research found that of 1.2 million adults who received at least one dose of either the Pfizer, Moderna, or AstraZeneca vaccine, fewer than 0.5% tested positive for COVID-19 14 days after their first dose.
![1]()
News
Limited evidence for interventions to reduce post-op pulmonary complications
September 1, 2021
Do perioperative interventions reduce postoperative pulmonary complications (PPCs) in patients undergoing noncardiac surgery?
![1]()
News
Two swings, two misses with colchicine, Vascepa in COVID-19
September 1, 2021
The study cohorts varied from healthcare and public workers at high risk for infection to individuals already hospitalized with COVID-19.
![1]()
News
‘Deeper dive’ into opioid overdose deaths during COVID pandemic
September 1, 2021
Results also showed that, compared to 2019, significantly more men died from overdoses in 2020 in Colorado and Indiana.
![1]()
News
Early end for trial of experimental oxygenation strategies in ARDS
August 31, 2021
Does a conservative oxygenation strategy improve mortality in patients with acute respiratory distress syndrome (ARDS)?
![1]()
News
Genetic link may tie cannabis use disorder to severe COVID-19
August 27, 2021
“These data have important implications for policy regarding vaccination as well as treatment prioritization,” said lead author Dr. Alexander S. Hatoum.
![1]()
News
CRP as a biomarker for community-acquired pneumonia
August 24, 2021
Can biomarkers such as C-reactive protine (CRP) or procalcitonin be used as tools in diagnosis of outpatient CAP (community-acquired pneumonia)?
![1]()
News
Use of point-of-care ultrasound (POCUS) for heart failure
August 16, 2021
Hospitalist use of POCUS may include guiding procedures, aiding in diagnosis, and assessing effectiveness of treatment.
News
COVID-19 mitigation measures led to shifts in typical annual respiratory virus patterns
August 11, 2021
“Clinicians should be aware of increases in some respiratory virus activity and remain vigilant for off-season increases.”
![1]()
News
Injectable monoclonal antibodies prevent COVID-19 in trial
August 6, 2021
The cocktail of casirivimab and imdevimab reduced the relative risk of infection by 72% in patients at high risk of infection.
